Specifically, we propose utilizing targeted antibiotics to eradicate KP and suppress PAMPs release, modulating macrophage responses through enhancement of autophagy and apoptosis for rapid KP clearance, and selectively inhibiting pyroptosis and necroptosis in severe infections to prevent inflammatory cascades. The gene discussed is NPPA; the disease is infection.